Area Abbonati

About the journal


The Italian Journal of Gender-Specific Medicine is a four-monthly journal that aims to make a contribution to the greater development and diffusion of a gender-specific medicine culture in Italy.

The publication’s mission is to promote not merely Italian research experiences – including basic, clinical and translational research – but also social and political and cultural contexts.

The journal addresses healthcare professionals, decision-makers, experts in economics and bioethics and clinical and pharmacological research; it is intended for all those interested in the gender dimension in healthcare.

The journal publishes news (from the world and from Italy), interviews, reviews, original articles (interventional and observational studies or qualitative analyses), contributions on social policy in the gender-specific policy field.

It is published by Il Pensiero Scientifico Editore, in association with Novartis, sponsor of the initiative.


Editorial policies and ethics

Conflicts of interest, authorship, ethical aspects. In general, the journal makes reference to the document of the International Committee of Medical Journal Editors (ICMJE). This is a constantly updated position statement. A letter is required to ensure that the work is unpublished, to confirm the transfer of literary ownership of the article to the publishing house, to declare the absence of conflicts of interest and to suggest the section of the journal in which the author would like to have the work published. In the case of articles signed by several authors, a declaration is required stating the individual contribution made to the preparation of the article. All authors must have contributed to the conception of the content and the latest revision.

Conflicts of interest. Particular attention should be paid to the declaration of the possible existence of economic conflicts of interest. The latter, in fact, if expressed, do not constitute grounds for penalisation in the evaluation of the work. On the contrary, should the editors or reviewers determine the existence of potentially conflicting interests (participation in satellite symposia or involvement in research projects) not declared by one or more authors, this may constitute a reason for rejecting the publication proposal.
The journal editorial staff does not consider such possible conflicts of interest as “cultural or intellectual”. In other words, having spoken positively or negatively about classes of drugs, specific approaches to clinical practice or health policy strategies is not a reason for prejudice in the evaluation of proposed content.

Plagiarism. It may seem obvious, but the importance of not drawing content from sources that are not mentioned in the bibliography is stressed. Publishing houses now have software or control techniques that are able to discover almost all attempts at plagiarism already in the phase of editorial review of the contributions.

Peer review. All received articles are subject to a critical review to assess their formal and content aspects. Articles can be accepted without revisions, accepted with minor revisions, accepted only after ‘major’ revision, or rejected.
For commissioned articles - for example, Editorials or Reviews - revision is generally limited to formal aspects and is carried out only by the editorial staff of the journal.

Authorship. It is important that only those who actually contributed to the preparation of the content are listed as authors. The conditions for signing a work are those described in the editorial by Phil Fontanarosa et al. published in JAMA in December 2017: Fontanarosa P, Bauchner H, Flanagin A. Authorship and team science. JAMA 2017; 318(24):.

Il Pensiero Scientifico Editore
Riproduzione e diritti riservati  |   ISSN online: 2612-3487